MILAN, Italy– Demetra Holding, an innovative and independent international medical company leader in providing anti-infective cements, spacers and biomaterials for orthopedic applications, today announced its acquisition of a 51% stake in GetSet Surgical, a leading Swiss-based spine surgical solutions provider.
The acquisition marks a significant step in Demetra Holding’s strategy to broaden its offerings in the Spine sector. The collaboration will combine Demetra’s existing technologies with GetSet’s expertise in sterile spine procedure kits, creating a comprehensive spinal/orthopedic product lineup designed to reduce infection risks, optimize hospital efficiency and contribute to environment sustainability.
This investment will integrate the strengths of both companies, establishing a new approach to spine and orthopedic procedures. The use of sterile-packaged disposable implants and instruments helps to reduce the risk of infections and hospital costs associated with central sterilization issues, aligning directly with Demetra’s mission of becoming the company of choice for infection management and efficiency through its portfolio companies: Tecres, OSARTIS, OsteoRemedies and Yijiutai.
As a result of this acquisition, both companies will be able to offer integrated solutions that promote patient safety and operational efficiency, as well as environment sustainability, key objectives in modern healthcare.
Michele Perrino, CEO of Demetra Holding, commented: “Demetra Holding is proud to spearhead this collaboration, as it aligns perfectly with our mission to enhance healthcare solutions focused on orthopedic infection management strategies worldwide. By combining the innovative capabilities of GetSet Surgical with our existing product offerings, we are striving to create and become the premier choice for surgeons and their patients in the single-use, sterile packaged spinal procedure market.”
Ole Stoklund, founder and CEO of GetSet Surgical stated: “The integration of GetSet’s cutting-edge sterile packaged spine procedure kits with Demetra Holding’s robust portfolio and resources will significantly enhance our mutual commitment to minimizing infection risks and optimizing operational efficiencies in hospitals and the emerging ASC market.”
As part of its expansion plans, Demetra Holding is prioritizing the introduction of GetSet’s products into the United States market. The newly established US Spine Division of Demetra’s portfolio company OsteoRemedies will manage the distribution of these products. This division will be headed by Ted Bird, an industry veteran recently appointed Vice President Spine Commercial.
The initial US product offerings will include GetSet’s GoPLF!™ Posterior Lateral Fusion system, already FDA approved. Introduction of GetSet’s GoLIF!™ Lumbar Interbody Fusion system is anticipated to take place later this year following FDA 510(k) clearance which is pending. Additional systems already in development will be expedited by this new investment.
